Editing Bausch & Lomb (section)

===PureVision===
Bausch + Lomb was in a lawsuit with [[Novartis]] which claimed to have [[patent]]s on a Bausch + Lomb product called PureVision. On June 26, 2002, a federal judge ruled that Bausch & Lomb did infringe on [[Ciba Vision]] (a subsidiary of Alcon) patents.<ref name="NYTimes">{{cite news
  | title =  Company News: Bausch + Lomb is found guilty of patent infringement
  | date = 2002-07-27
  | work = [[The New York Times]]
  | url = https://query.nytimes.com/gst/fullpage.html?res=9E04E6DD123EF934A15755C0A9649C8B63&n=Top%2fNews%2fScience%2fTopics%2fInventions%20and%20Patents
  | access-date = 2007-04-19
}}</ref>

On July 2, 2004, the company announced that it had licensed the intellectual property of Novartis.<ref name="Settlement">{{cite news
 |title=Bausch & Lomb, Ciba Vision reach settlement of patent litigation
 |url=http://findarticles.com/p/articles/mi_qn4180/is_20040707/ai_n10070038
 |archive-url=https://web.archive.org/web/20090220065342/http://findarticles.com/p/articles/mi_qn4180/is_20040707/ai_n10070038
 |url-status=dead
 |archive-date=2009-02-20
 |date=2004-07-07
 |access-date=2007-04-19
 |publisher=The Daily Record (Rochester, New York)
}}</ref> Bausch & Lomb will pay the Ciba Vision unit of Novartis a royalty on net U.S. sales of its PureVision brand contact lenses until 2014 and on net sales outside the U.S. until 2016. But as of now, the brand FreshLook comes under Bausch and Lomb and Ciba manufacturers it.